Gene · 92521
Papers3,158
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,921 to 1,940 of 3,158
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| COVID-19: Discovery, diagnostics and drug development. | J Hepatol | 2021 | 33038433 | PubTator, text mining | PubMed |
| Genetics and genomics of SARS-CoV-2: A review of the literature with the special focus on genetic diversity and SARS-CoV-2 genome detection. | Genomics | 2021 | 33007398 | PubTator, text mining | PubMed |
| Flavonoids: A complementary approach to conventional therapy of COVID-19? | Phytochem Rev | 2021 | 32982616 | PubTator, text mining | PubMed |
| Covid-19.bioreproducibility.org: A web resource for SARS-CoV-2-related structural models. | Protein Sci | 2021 | 32981130 | PubTator, text mining | PubMed |
| Causes of acute gastroenteritis in Korean children between 2004 and 2019. | Clin Exp Pediatr | 2021 | 32972055 | PubTator, text mining | PubMed |
| Viral pandemic preparedness: A pluripotent stem cell-based machine-learning platform for simulating SARS-CoV-2 infection to enable drug discovery and repurposing. | Stem Cells Transl Med | 2021 | 32961040 | PubTator, text mining | PubMed |
| RNA-dependent RNA polymerase: Structure, mechanism, and drug discovery for COVID-19. | Biochem Biophys Res Commun | 2021 | 32943188 | PubTator, text mining | PubMed |
| Potential Pathogenicity Determinants Identified from Structural Proteomics of SARS-CoV and SARS-CoV-2. | Mol Biol Evol | 2021 | 32941612 | PubTator, text mining | PubMed |
| An Experimental and Theoretical Approach to Understand Fever, DENF & its Cure. | Infect Disord Drug Targets | 2021 | 32888275 | PubTator, text mining | PubMed |
| Cats and kids: how a feline disease may help us unravel COVID-19 associated paediatric hyperinflammatory syndrome. | Infection | 2021 | 32880100 | PubTator, text mining | PubMed |
| Why do SARS-CoV-2 NSPs rush to the ER? | J Neurol | 2021 | 32870373 | PubTator, text mining | PubMed |
| Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis. | Med | 2021 | 32838362 | PubTator, text mining | PubMed |
| Remdesivir and its antiviral activity against COVID-19: A systematic review. | Clin Epidemiol Glob Health | 2021 | 32838064 | PubTator, text mining | PubMed |
| Chemical-informatics approach to COVID-19 drug discovery: Exploration of important fragments and data mining based prediction of some hits from natural origins as main protease (Mpro) inhibitors. | J Mol Struct | 2021 | 32834115 | PubTator, text mining | PubMed |
| SARS-CoV-2 nucleocapsid and Nsp3 binding: an in silico study. | Arch Microbiol | 2021 | 32749662 | PubTator, text mining | PubMed |
| Genetic comparison among various coronavirus strains for the identification of potential vaccine targets of SARS-CoV2. | Infect Genet Evol | 2021 | 32745811 | PubTator, text mining | PubMed |
| Antiviral activity of green tea and black tea polyphenols in prophylaxis and treatment of COVID-19: A review. | Phytomedicine | 2021 | 32741697 | PubTator, text mining | PubMed |
| Understanding COVID-19 via comparative analysis of dark proteomes of SARS-CoV-2, human SARS and bat SARS-like coronaviruses. | Cell Mol Life Sci | 2021 | 32712910 | PubTator, text mining | PubMed |
| The rationale for a multi-step therapeutic approach based on antivirals, drugs and nutrients with immunomodulatory activity in patients with coronavirus-SARS2-induced disease of different severities. | Br J Nutr | 2021 | 32703328 | PubTator, text mining | PubMed |
| Contributory role of SARS-CoV-2 genomic variations and life expectancy in COVID-19 transmission and low fatality rate in Africa. | Egypt J Med Hum Genet | 2020 | 38624543 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/papers?page=97